Full Text View
Tabular View
No Study Results Posted
Related Studies
Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels
This study is currently recruiting participants.
Study NCT00851370.   Last updated on February 24, 2009.
Information provided by National Jewish Health
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Chronic Disease
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiration Disorders
More general conditions related to this trial
Disease Attributes
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
Omalizumab (Xolair)
Placebo
Additional drug interventions recognized in this trial
Omalizumab
More general drug interventions related to this trial
Anti-Allergic Agents
Anti-Asthmatic Agents
Pharmacologic Actions
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
National Jewish Health
Novartis


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services